These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review. Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436 [TBL] [Abstract][Full Text] [Related]
25. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis. Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954 [TBL] [Abstract][Full Text] [Related]
26. [Severe course of a mutilating pansclerotic circumscribed scleroderma in childhood. Clinical aspects and therapy]. Stücker M; Schreiber D; Gruss C; Freitag M; von Kobyletzki G; Kerscher M; Altmeyer P Hautarzt; 1999 Feb; 50(2):131-5. PubMed ID: 10097957 [TBL] [Abstract][Full Text] [Related]
27. Pansclerotic morphea with features of eosinophilic fasciitis: distinct entities or part of a continuum? Odhav A; Hoeltzel MF; Canty K Pediatr Dermatol; 2014; 31(2):e42-7. PubMed ID: 24383741 [TBL] [Abstract][Full Text] [Related]
28. Development of keloidal morphea after treatment with cyclosporine in a case of recalcitrant generalized morphea. Dadkhahfar S; Asadi Kani Z; Araghi F; Moravvej H Clin Case Rep; 2020 May; 8(5):837-839. PubMed ID: 32477528 [TBL] [Abstract][Full Text] [Related]
29. Morphea and Eosinophilic Fasciitis: An Update. Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481 [TBL] [Abstract][Full Text] [Related]
30. [Diagnostic and therapeutic problems of scleroderma]. Pogorzelska-Antkowiak A; Antkowiak R Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489 [TBL] [Abstract][Full Text] [Related]
31. Classification of morphea (localized scleroderma). Peterson LS; Nelson AM; Su WP Mayo Clin Proc; 1995 Nov; 70(11):1068-76. PubMed ID: 7475336 [TBL] [Abstract][Full Text] [Related]
32. Deep morphea. Bielsa I; Ariza A Semin Cutan Med Surg; 2007 Jun; 26(2):90-5. PubMed ID: 17544960 [TBL] [Abstract][Full Text] [Related]
33. Phototherapy: a promising treatment option for skin sclerosis in scleroderma? Sunderkötter C; Kuhn A; Hunzelmann N; Beissert S Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii52-iii54. PubMed ID: 16987838 [TBL] [Abstract][Full Text] [Related]
34. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182 [TBL] [Abstract][Full Text] [Related]
35. Metastatic Squamous Cell Carcinoma in a Patient with Disabling Pansclerotic Morphea of Childhood. Ruiz-Matta JM; Flores-Bozo LR; Dominguez-Cherit J Pediatr Dermatol; 2017 Jul; 34(4):e164-e167. PubMed ID: 28543434 [TBL] [Abstract][Full Text] [Related]
37. Scleroderma: what the general dentist should know. Spackman GK Gen Dent; 1999; 47(6):576-9. PubMed ID: 10687451 [TBL] [Abstract][Full Text] [Related]